Clinical Trial Update: A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 safety, tolerability, efficacy and exposure study of XEN801 Topical Gel in acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• XEN801 Topical Gel (XEN801)

Snippet

Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: COMPLETED